13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0000902664-23-004379
Total Value
$75.7M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 7,050,000 | $25.7M | 33.91% |
| 2 | ROCKET PHARMACEUTICALS INC | RCKTW | 630,380 | $12.5M | 16.55% |
| 3 | INVIVYD INC | IVVD | 9,248,250 | $9.7M | 12.83% |
| 4 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 197,700 | $5.2M | 6.85% |
| 5 | CURIS INC | CRIS | 6,000,000 | $5.0M | 6.58% |
| 6 | STOKE THERAPEUTICS INC | STOK | 346,190 | $3.7M | 4.86% |
| 7 | TG THERAPEUTICS INC | TGTX | 142,500 | $3.5M | 4.68% |
| 8 | PROQR THRAPEUTICS N V | N71542109 | 1,910,600 | $3.1M | 4.09% |
| 9 | BRIDGEBIO PHARMA INC | BBIO | 166,200 | $2.9M | 3.78% |
| 10 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $2.4M | 3.18% |
| 11 | SILENCE THERAPEUTICS PLC | SLNCF | 363,800 | $2.0M | 2.64% |
| 12 | NEXIMMUNE INC | 65344D109 | 133,442 | $37,604 | 0.05% |